VaramirStart free · no cardSign in
GLUE as of Nov 1 · 09:29 ET
GLUENasdaqBiological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc. · Brief

Next report

4 days

Nov 5 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±22.5%
avg realized
±4.2%
Jan 10 '25±16.7%▼−4.84%×0.29
Mar 20 '25±15.1%▲+5.37%×0.36
May 8 '25±24.1%▲+9.61%×0.40
Aug 7 '25±40.0%▼−2.87%×0.07
Nov 6 '25±18.2%▲+5.69%×0.31
Q1 FY26±24.5%▼−1.96%×0.08
May 7 '26±25.6%▼−2.84%×0.11
Q2 FY26±15.6%▲+0.64%×0.04
quarterimplied−40%0+40%realized×
Q2 FY26±15.6%▲+0.64%×0.04
May '26±25.6%▼−2.84%×0.11
Q1 FY26±24.5%▼−1.96%×0.08
Nov '25±18.2%▲+5.69%×0.31
Aug '25±40.0%▼−2.87%×0.07
May '25±24.1%▲+9.61%×0.40
2 older reports
Mar '25±15.1%▲+5.37%×0.36
Jan '25±16.7%▼−4.84%×0.29
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2

194managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+9.12%change in shares held by the largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

4tracked funds holding GLUEN-PORT · Aug 31 '26
0.48%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

GLUE report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±15.2% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.